Matches in SemOpenAlex for { <https://semopenalex.org/work/W2436996972> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W2436996972 endingPage "83" @default.
- W2436996972 startingPage "668" @default.
- W2436996972 abstract "The purpose of this review is to discuss the role of mexiletine, tocainide, flecainide, and amiodarone in the treatment of patients with symptomatic ventricular ectopy or sustained ventricular tachycardia (VT) and fibrillation (VF). The pharmacologic properties, electrophysiologic effects, clinical efficacy, adverse reactions, and costs of these new agents are compared with those of procainamide, quinidine, and disopyramide. With the exception of more convenient dosing intervals, these new agents do not afford novel or advantageous pharmacologic properties. The incidences and severity of adverse reactions are similar to those reported with conventional antiarrhythmic drugs. Results of clinical studies demonstrate that these newer drugs are comparable to procainamide, quinidine, and disopyramide in suppressing ventricular ectopy. Accordingly, the choice of an antiarrhythmic agent for patients with symptomatic ventricular ectopy can be based on the side-effect profile. The propensity for developing certain adverse effects can be defined if patients are subgrouped by age and left ventricular function. The adverse effects of amiodarone preclude its use in patients manifesting only ventricular ectopy. Treatment of patients with sustained VT/VF is more complex. Mexiletine and tocainide are generally not effective. The efficacy of flecainide is similar to that of procainamide, quinidine, and disopyramide. The negative inotropic effects of flecainide and disopyramide preclude their use in patients with severe ventricular dysfunction. Amiodarone is the most effective of these drugs for preventing recurrences of sustained VT/VF. Its use should, however, be restricted to patients refractory or intolerant to other antiarrhythmic drugs." @default.
- W2436996972 created "2016-06-24" @default.
- W2436996972 creator A5020089698 @default.
- W2436996972 date "1988-07-01" @default.
- W2436996972 modified "2023-09-23" @default.
- W2436996972 title "The role of newer antiarrhythmic drugs in the management of patients with ventricular arrhythmias." @default.
- W2436996972 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3044200" @default.
- W2436996972 hasPublicationYear "1988" @default.
- W2436996972 type Work @default.
- W2436996972 sameAs 2436996972 @default.
- W2436996972 citedByCount "1" @default.
- W2436996972 crossrefType "journal-article" @default.
- W2436996972 hasAuthorship W2436996972A5020089698 @default.
- W2436996972 hasConcept C126322002 @default.
- W2436996972 hasConcept C164705383 @default.
- W2436996972 hasConcept C197934379 @default.
- W2436996972 hasConcept C2776331378 @default.
- W2436996972 hasConcept C2777008848 @default.
- W2436996972 hasConcept C2777028498 @default.
- W2436996972 hasConcept C2777561782 @default.
- W2436996972 hasConcept C2778094803 @default.
- W2436996972 hasConcept C2778131192 @default.
- W2436996972 hasConcept C2779161974 @default.
- W2436996972 hasConcept C2779831137 @default.
- W2436996972 hasConcept C2779837460 @default.
- W2436996972 hasConcept C2780074459 @default.
- W2436996972 hasConcept C2780339425 @default.
- W2436996972 hasConcept C42219234 @default.
- W2436996972 hasConcept C71924100 @default.
- W2436996972 hasConceptScore W2436996972C126322002 @default.
- W2436996972 hasConceptScore W2436996972C164705383 @default.
- W2436996972 hasConceptScore W2436996972C197934379 @default.
- W2436996972 hasConceptScore W2436996972C2776331378 @default.
- W2436996972 hasConceptScore W2436996972C2777008848 @default.
- W2436996972 hasConceptScore W2436996972C2777028498 @default.
- W2436996972 hasConceptScore W2436996972C2777561782 @default.
- W2436996972 hasConceptScore W2436996972C2778094803 @default.
- W2436996972 hasConceptScore W2436996972C2778131192 @default.
- W2436996972 hasConceptScore W2436996972C2779161974 @default.
- W2436996972 hasConceptScore W2436996972C2779831137 @default.
- W2436996972 hasConceptScore W2436996972C2779837460 @default.
- W2436996972 hasConceptScore W2436996972C2780074459 @default.
- W2436996972 hasConceptScore W2436996972C2780339425 @default.
- W2436996972 hasConceptScore W2436996972C42219234 @default.
- W2436996972 hasConceptScore W2436996972C71924100 @default.
- W2436996972 hasIssue "7 Pt 2" @default.
- W2436996972 hasLocation W24369969721 @default.
- W2436996972 hasOpenAccess W2436996972 @default.
- W2436996972 hasPrimaryLocation W24369969721 @default.
- W2436996972 hasRelatedWork W1993816905 @default.
- W2436996972 hasRelatedWork W2021105832 @default.
- W2436996972 hasRelatedWork W2023928221 @default.
- W2436996972 hasRelatedWork W2024137326 @default.
- W2436996972 hasRelatedWork W2063027814 @default.
- W2436996972 hasRelatedWork W2085883978 @default.
- W2436996972 hasRelatedWork W2412083542 @default.
- W2436996972 hasRelatedWork W2436996972 @default.
- W2436996972 hasRelatedWork W580815681 @default.
- W2436996972 hasRelatedWork W90383406 @default.
- W2436996972 hasVolume "39" @default.
- W2436996972 isParatext "false" @default.
- W2436996972 isRetracted "false" @default.
- W2436996972 magId "2436996972" @default.
- W2436996972 workType "article" @default.